BridgeBio Oncology Therapeutics, In (BBOT) PT Raised to $32 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Andrew Berens raised the price target on BridgeBio Oncology Therapeutics, In (NASDAQ: BBOT) to $32.00 (from $25.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
